Notice Number: NOT-OD-05-017

Key Dates
Release Date: December 16, 2004

This notice is to inform applicants that two additional participants have been added to PAR-05-026. The Office of Research on Women's Health (ORWH) and the National Institute on Drug Abuse (NIDA) will participate in the program announcement.

The contact for the Office of Research on Women's Health is as follows:

Eleanor Z. Hanna, Ph.D.
Associate Director for Special Projects and Centers
Office of Research on Women's Health
Office of the Director
National Institutes of Health
Executive Plaza South 150A
6120 Executive Boulevard
Bethesda, Maryland 20892-7116
Telephone: (301) 435-1573
FAX: (301) 402-0005
E-mail:  hannae@od.nih.gov

The National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov/), has a long tradition of involving the community in its efforts to understand, reduce, prevent, and treat drug abuse and its adverse health and social consequences. Involving community partners and collaborators in drug abuse and HIV/AIDS research, for example, has informed NIDA's efforts to develop and implement culturally appropriate, community-based HIV/AIDS outreach interventions to avert the spread of new HIV infections among drug users, particularly in communities where health disparities exist. When drug abuse prevention and treatment programs are developed with the community's participation, the community becomes instrumental in their successful implementation and acceptance. Community-based participatory research has contributed to NIDA's mission to improve the effectiveness of drug abuse prevention and services programs in reaching persons at highest risk.

NIDA is interested in community-based, community level, and/or community participatory research on drug abuse, drug addiction, and drug-use related health and social consequences, and in the development of effective strategies to promote drug-free lifestyles, prevent drug abuse and its consequences, and eliminate health disparities. Studies are encouraged that examine:

• Community factors related to drug abuse, addiction, and its associated adverse behavioral, social, and health outcomes within and across racial/ethnic minority populations and their communities;
• The interrelationships of community characteristics, including structural factors (socioeconomic status, community resources, and environmental characteristics) on drug abuse and the transmission of HIV/AIDS and other infectious diseases;
• Community norms, attitudes, and beliefs toward drug abuse and addiction, drug-related activity, policing activities, and the establishment and maintenance of prevention programs and treatment services in the neighborhood;
• Strategies to improve and develop innovative community-partnered approaches to enhance long-term community-based participation in research on drug abuse and its health and social consequences, including the implementation of sustainable prevention, treatment, and services programs.

NIDA Contact:
Elizabeth Y. Lambert, M.Sc.
Epidemiology Research Branch
Division of Epidemiology, Prevention, and Services Research
National Institute on Drug Abuse
6001 Executive Blvd., Room 5169, MSC 9589,
Bethesda, Maryland 20892-2589
Telephone: (301) 402-1933
FAX: (301) 443-2636
E-mail: el46i@nih.gov

NIDA Grants Management Contact:
Gary Fleming, J.D.
Chief, Grants Management Branch/OPRM
National Institute on Drug Abuse
6101 Executive Blvd., Room 270
Bethesda, Maryland 20892
Telephone: (301) 443-6710
FAX: (301) 594-6849
E-mail: gfleming@nida.nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health® Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.